Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06115486 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Sep 20, 2024, no change to tracked fieldsv4-v5
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Mar 2025 to Jan 2027
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2023 to Jan 9, 2024
    v3
  3. Interventions: Exercise Regimen (Other) to Control Arm ACSM Guidelines (Other), Experimental Arm 6-12-25 repetitions per set (Other)
    • Eligibility criteria shortened, about 6 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this research study is to evaluate the outcomes of two standard of care group exercise regimens to increase muscle mass in women who have been treated with breast cancer.
Trial Details
NCT Number NCT06115486
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions
(from sponsor)		 Breast Cancer, Breast Carcinoma in Situ, Breast Cancer Female
Related terms Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma in Situ, Hypertrophy, Motor Activity, Neoplasms
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov